title: [The prediction of blood pressure after adrenalectomy in primary aldosteronism].
abstract: In 30-40% of patients with primary aldosteronism owing to adenoma, hypertension is not relieved even though a hyper-functioning adenoma has been completely removed. The purpose of this study is to determine whether the prognosis of hypertension can be evaluated pre-operatively in patients with primary aldosteronism. Thirteen patients (6 men, 7 women; 47 +/- 9 years old) with primary aldosteronism were studied and adrenalectomy was performed in all cases. The success of the operation was confirmed by the normalization of plasma renin activity (PRA), plasma aldosterone concentration (PAC) and serum potassium. Eight patients, 3 men and 5 women, whose blood pressure (BP) was reduced to below 140mmHg systolic and 90mmHg diastolic at one year after the operation were classified as "group N" and the other 5 cases, 3 men and 2 women, remained hypertensive and were classified as "group H". There were no significant differences in the age of the patients, duration of hypertension, pretreatment mean BP and severity of hypertension between the two groups. Thus, it is doubtful that the lack of improvement of hypertension is due to the irreversible damage of the small arteries. Although pretreatment BP was similar in the two groups, systolic BP after the administration of 200mg per day of spironolactone for one week was significantly reduced in group N, but not in group H. Moreover, a significant correlation was found between mean BP after treatment with spironolactone and post-operative mean BP in all subjects. Pretreatment PRA was significantly lower in group H.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: First Department of Internal Medicine, Hiroshima University School of Medicine.
authors.forename: K
authors.initials: K
authors.lastname: Ishibashi
authors.forename: H
authors.initials: H
authors.lastname: Matsuura
authors.forename: M
authors.initials: M
authors.lastname: Watanabe
authors.forename: M
authors.initials: M
authors.lastname: Ishida
authors.forename: T
authors.initials: T
authors.lastname: Ishida
authors.forename: R
authors.initials: R
authors.lastname: Ozono
authors.forename: K
authors.initials: K
authors.lastname: Kido
authors.forename: H
authors.initials: H
authors.lastname: Mitsuda
authors.forename: T
authors.initials: T
authors.lastname: Oshima
authors.forename: M
authors.initials: M
authors.lastname: Kanbe
mesh_terms: D000315:Adrenalectomy; D000328:Adult; D000450:Aldosterone / Q000097:blood; D001794:Blood Pressure; D005260:Female; D005665:Furosemide; D006801:Humans; D006929:Hyperaldosteronism / Q000503:physiopathology* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012083:Renin / Q000097:blood; D013148:Spironolactone / Q000008:administration & dosage
chemical_list: D013148:Spironolactone; D000450:Aldosterone; D005665:Furosemide; D012083:Renin